0001567619-21-004128.txt : 20210216
0001567619-21-004128.hdr.sgml : 20210216
20210216190041
ACCESSION NUMBER: 0001567619-21-004128
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210215
FILED AS OF DATE: 20210216
DATE AS OF CHANGE: 20210216
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Dobson Mitchell D
CENTRAL INDEX KEY: 0001756677
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-10670
FILM NUMBER: 21641808
MAIL ADDRESS:
STREET 1: 10910 DOMAIN DRIVE, SUITE 300
CITY: AUSTIN
STATE: TX
ZIP: 78758
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: HANGER, INC.
CENTRAL INDEX KEY: 0000722723
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-SPECIALTY OUTPATIENT FACILITIES, NEC [8093]
IRS NUMBER: 840904275
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 10910 DOMAIN DRIVE
STREET 2: SUITE 300
CITY: AUSTIN
STATE: TX
ZIP: 78758
BUSINESS PHONE: 512-777-3800
MAIL ADDRESS:
STREET 1: 10910 DOMAIN DRIVE
STREET 2: SUITE 300
CITY: AUSTIN
STATE: TX
ZIP: 78758
FORMER COMPANY:
FORMER CONFORMED NAME: HANGER ORTHOPEDIC GROUP INC
DATE OF NAME CHANGE: 19920703
FORMER COMPANY:
FORMER CONFORMED NAME: SEQUEL CORP
DATE OF NAME CHANGE: 19890814
FORMER COMPANY:
FORMER CONFORMED NAME: CELLTECH COMMUNICATIONS INC
DATE OF NAME CHANGE: 19860304
4
1
doc1.xml
FORM 4
X0306
4
2021-02-15
0
0000722723
HANGER, INC.
HNGR
0001756677
Dobson Mitchell D
10910 DOMAIN DRIVE, SUITE 300
AUSTIN
TX
78758
0
1
0
0
SVP, Chief Compliance Officer
Common Stock
2021-02-15
4
A
0
3583
0
A
32360
D
Represents performance shares being issued to the reporting person based on the achievement of performance targets for the period beginning January 1, 2020 and ending on December 31, 2020. These performance shares vest in equal tranches over a four year period, commencing on the first anniversary of the grant date.
Consists of (i) unvested restricted shares totaling 3,583 shares of stock from an initial grant of 3,583 shares of restricted stock that begins to vest on March 9, 2021; (ii) unvested restricted shares totaling 4,215 shares of stock from an initial grant of 4,215 shares of restricted stock that begins to vest on March 9, 2021; (iii) unvested restricted shares and fully vested shares totaling 3,619 shares of stock from an initial grant of 3,854 shares of restricted stock made on March 8, 2019 (iv) unvested restricted shares and fully vested shares totaling 4,289 shares of stock from an initial grant of 4,567 shares of restricted stock made on March 8, 2019; [continued in next footnote]
(v) unvested restricted shares and fully vested shares totaling 4,209 shares of stock from an initial grant of 5,000 shares of restricted stock made on March 9, 2018; (vi) unvested restricted shares and fully vested shares totaling 3,774 shares of stock from an initial grant of 5,000 shares of restricted stock made on March 8, 2017; (vii) unvested restricted shares and fully vested shares totaling 2,667 shares of stock from an initial grant of 4,150 shares of restricted stock made on April 29, 2016; [continued in next footnote]
(viii) fully vested shares totaling 1,247 shares of stock from an initial grant of 1,653 shares of restricted stock made on November 10, 2015; (ix) fully vested shares totaling 119 shares of stock from an initial grant of 200 shares of restricted stock made on March 6, 2015; (x) fully vested shares totaling 2,179 shares of stock from an initial grant of 3,604 shares of restricted stock made on March 6, 2015; (xi) fully vested shares totaling 990 shares of stock from an initial grant of 1,598 shares of restricted stock made on March 7, 2014; (xii) fully vested shares totaling 827 shares of stock from an initial grant of 1,800 shares of restricted stock made on March 11, 2013; (xiii) fully vested shares totaling 428 shares from an initial grant of 1,400 shares of restricted stock made on March 7, 2012; [continued in next footnote]
and (xiv) fully vested shares totaling 214 shares from an initial grant of 1,400 shares of restricted stock made on March 25, 2011.
Except as otherwise noted, all remaining unvested restricted shares will continue to vest at a rate of 25% per year of the original grant amount on the anniversary date of the grant.
/s/ Jessica Lochmann Allen, Attorney-in-Fact for Mitchell D. Dobson
2021-02-16